Latest News about LEGN
Recent news which mentions LEGN
From Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
February 27, 2022
From Benzinga
Attention Biotech Investors: Mark Your Calendar For These Key February PDUFA Dates
February 01, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2022
January 31, 2022
From Benzinga
18 Stocks Moving in Thursday's Pre-Market Session
December 16, 2021
From Benzinga
46 Biggest Movers From Yesterday
December 16, 2021
From Benzinga
36 Stocks Moving In Wednesday's Mid-Day Session
December 15, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 15, 2021
From Benzinga
The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO
December 15, 2021
From Benzinga
From InvestorPlace
20 Stocks Moving in Wednesday's Pre-Market Session
December 15, 2021
From Benzinga
JNJ's Janssen Posts Two Years Survival Data On BCMA Cell Therapy In Multiple Myeloma
December 13, 2021
From Benzinga
80 Biggest Movers From Yesterday
November 17, 2021
From Benzinga
53 Stocks Moving In Tuesday's Mid-Day Session
November 16, 2021
From Benzinga
Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates
November 02, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 02, 2021
From Benzinga
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 01, 2021
From Benzinga
2 Upcoming FDA Approval Decisions That Investors Should Really Watch
October 23, 2021
From Motley Fool
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
From Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
October 01, 2021
From Benzinga
Here's Why Ziopharm Oncology Stock Is Up 18% This Week
September 10, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.